Stefanie Märschenz

Years Active: 2018-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Otte, Woo Ri Chae, Jan Nowacki, Michael Kaczmarczyk, Dominique Piber, Stefan Roepke, Stefanie Märschenz, Sandra Lischewski, Sein Schmidt, Barbara Ettrich, Hans Joergen Grabe, Ulrich Hegerl, Kim Hinkelmann, Tobias Hofmann, Deborah Janowitz, Klaus Junghanns, Kai G Kahl, Jan-Philipp Klein, Tillmann H C Krueger, Gregor Leicht, David Prvulovic, Andreas Reif, Daniel Schoettle, Maria Strauss, Anna Westermair, Tim Friede, Stefan M Gold
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial. BMJ open 10 (12) (2020)
Siegfried Kohler, Stefanie Märschenz, Ulrike Grittner, Tobias Alexander, Falk Hiepe, Andreas Meisel
Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial. BMJ open 9 (1) (2019)
Daniel Strech, Sören Sievers, Stefanie Märschenz, Nico Riedel, Susanne Wieschowski, Jörg Meerpohl, Holger Langhof, Stephanie Müller-Ohlraun, Ulrich Dirnagl
Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables. F1000Research 7 (2018)

Stefanie Märschenz.css-eqlu8i{font-size:small;padding-left:4px;}